WEDNESDAY, Oct. 14, 2020 — Sitagliptin treatment added to standard care is associated with reduced mortality and improved clinical outcomes…
Read More
Hair loss. Memory problems. Strange rashes. COVID-19 patients report a litany of symptoms outside official criteria
Julie Sciascia-Van Horn was hospitalized with COVID-19 in early April, suffering from some of the typical flu-like symptoms associated with…
Read More
Influenza vaccination may provide roadmap to prevent COVID-19 in cardiovascular disease patients
Seasonal influenza vaccine development and mass production, as well as three international influenza vaccine cardiovascular outcomes trials currently underway, may…
Read More
8 in 10 COVID-19 Patients Suffer Neurological Symptoms, Study Finds
MONDAY, Oct. 5, 2020 — As President Donald Trump battles the coronavirus, researchers reveal concerning new findings: Neurological symptoms occur…
Read More
Researchers develop more accurate surgery-risk predictor for patients with cirrhosis
Physicians and researchers at the Perelman School of Medicine at the University of Pennsylvania, the Corporal Michael J. Crescenz VA…
Read More![U.S. Food and Drug Administration Approves Haegarda (C1 Esterase Inhibitor Subcutaneous [Human]) for Prevention of Hereditary Angioedema (HAE) Attacks in Pediatric Patients](https://alternative-medicine-ny.com/wp-content/uploads/sites/31/2018/11/TQhauKsZaWagomfidiOJ.jpg)
U.S. Food and Drug Administration Approves Haegarda (C1 Esterase Inhibitor Subcutaneous [Human]) for Prevention of Hereditary Angioedema (HAE) Attacks in Pediatric Patients
KING OF PRUSSIA, PA – September 28, 2020 – CSL Behring, a global biotherapeutics leader, announced today that the U.S….
Read More
Having Flu and COVID Doubles Death Risk in Hospitalized Patients
TUESDAY, Sept. 22, 2020 (Healthday News) — While health officials worry about a potential “twindemic” of COVID-19 and the flu…
Read More
Stroke can be first presenting symptom of younger patients with COVID-19
Since the start of the COVID-19 pandemic, researchers have been working to better understand and characterize the varied symptoms of…
Read More
Combining tests at point of care dramatically increases COVID-19 detection in hospitalised patients
A Cambridge hospital has piloted the use of combined rapid point-of-care nucleic acid and antibody testing for SARS-CoV-2 infection after…
Read More
Registry tracks outcomes among thoracic cancer patients sickened by COVID-19
New data from TERAVOLT, a global consortium that tracks outcomes of people with thoracic cancers affected by COVID-19, offers clues…
Read More